Home > Insider Trading > Filing (0001140361-12-041210)

Filing Details

Accession Number:: 0001140361-12-041210
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-09-21 17:49:54
Reporting Period:: 2012-09-20

Filing Date:: 2012-09-21
Accepted Time:: 2012-09-21 17:49:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1323974	Mwi Veterinary Supply Inc.	MWIV	Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)	020620757

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1334044	Jr N Robert Rebholtz	3041 W. Pasadena Dr. Boise ID 83705		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value $0.01 Per Share	Disposition	2012-09-20	3,246	$106.72	53,834	No	4	S	Direct
Common Stock, Par Value $0.01 Per Share	Disposition	2012-09-20	400	$107.23	53,434	No	4	S	Direct
Common Stock, Par Value $0.01 Per Share	Disposition	2012-09-21	200	$107.75	53,234	No	4	S	Direct
Common Stock, Par Value $0.01 Per Share	Disposition	2012-09-21	6,871	$108.58	46,363	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.01 Per Share	168,760	Indirect	See footnote

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Robert N. Rebholtz Jr. on September 6, 2012.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $106.06 to $106.895, inclusive. Mr. Rebholtz has provided to MWI Veterinary Supply, Inc. ("the Company") and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $107.06 to $107.29, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $107.13 to $108.08, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $108.13 to $109.00, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Held by The Rebholtz Descendants' Trust DTD 10-4-96 for the benefit of Mr. Rebholtz's family and certain other persons. Mr. Rebholtz expressly disclaims beneficial ownership of any shares held by such trust that exceed his pecuniary interest therein.